Can the co-localization of CD8+, PD-1, PD-L1 AND PD-L2 patterns provide guidance in clinical evolution of patients with head and neck cutaneous squamous cell carcinoma?

Highlights • The co-localization of PD-1/PD-L1 could be a promising tool for prognostic evaluation.• The first study to assess co-localization of CD8, PD1, PDL1, PDL2 in cSCC.• Notable presence of CD8+T-cell infiltration in cSCC, co-localizing with PD-L1/L2.

• Publication year

  2025

• Venue

  Brazilian Journal of Otorhinolaryngology

• Publication date

  2025-05-24

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.bjorl.2025.101632PMID 40413814PMCID 12151684
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Comparing the eighth and the seventh editions of the American Joint Committee on Cancer staging system and the Brigham and Women's Hospital alternative staging system for cutaneous squamous cell carcinoma: Implications for clinical practice

  2019cited by this paper
• KEYNOTE-629: Phase 2 study of pembrolizumab for recurrent/metastatic or locally advanced unresectable cutaneous squamous cell carcinoma (cSCC).

  2019cited by this paper
• Systemic Immunotherapy for Advanced Cutaneous Squamous Cell Carcinoma

  2019cited by this paper
• Correlation Between PD-L2 Expression and Clinical Outcome in Solid Cancer Patients: A Meta-Analysis

  2019cited by this paper
• The prognostic role of PD-L1 expression for survival in head and neck squamous cell carcinoma: A systematic review and meta-analysis.

  2018cited by this paper
• PD‐1 Blockade with Cemiplimab in Advanced Cutaneous Squamous‐Cell Carcinoma

  2018cited by this paper
• Discovery and Analysis of Invertebrate IgVJ-C2 Structure from Amphioxus Provides Insight into the Evolution of the Ig Superfamily

  2018influential reference
• Programmed death‐1 ligands 1 and 2 expression in cutaneous squamous cell carcinoma and their relationship with tumour‐ infiltrating dendritic cells

  2017cited by this paper
• Soluble PD-1 and PD-L1: predictive and prognostic significance in cancer.

  2017cited by this paper
• The pattern and clinicopathological correlates of programmed death‐ligand 1 expression in cutaneous squamous cell carcinoma

  2017influential reference
• PD-L1 expression predicts longer disease free survival in high risk head and neck cutaneous squamous cell carcinoma.

  2017cited by this paper
• Programmed cell death ligand 1 as a biomarker in head and neck cancer

  2017cited by this paper
• Soluble PD-1 and PD-L1: predictive and prognostic significance in cancer

  2017cited by this paper
• Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade

  2017cited by this paper
• Expression of PD-1/PD-L1 and PD-L2 in peripheral T-cells from non-small cell lung cancer patients

  2017cited by this paper
• Tumor programmed cell death ligand 1 expression correlates with nodal metastasis in patients with cutaneous squamous cell carcinoma of the head and neck

  2017cited by this paper
• The role of antagonists of the PD-1:PD-L1/PD-L2 axis in head and neck cancer treatment.

  2016cited by this paper
• The PD1:PD-L1/2 Pathway from Discovery to Clinical Implementation

  2016cited by this paper
• Risk Factors for Cutaneous Squamous Cell Carcinoma Recurrence, Metastasis, and Disease-Specific Death: A Systematic Review and Meta-analysis.

  2016cited by this paper
• Biomarker and Pathologic Predictors of Cutaneous Squamous Cell Carcinoma Aggressiveness

  2016cited by this paper
• PD‐L1 expression in cutaneous squamous cell carcinoma correlates with risk of metastasis

  2016cited by this paper
• Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade

  2016cited by this paper
• Mutational landscape determines sensitivity to PD-1 blockade in non–small cell lung cancer

  2015cited by this paper
• Association of Polymerase e-Mutated and Microsatellite-Instable Endometrial Cancers With Neoantigen Load, Number of Tumor-Infiltrating Lymphocytes, and Expression of PD-1 and PD-L1.

  2015cited by this paper
• Tissue-based map of the human proteome

  2015cited by this paper
• Nivolumab versus Docetaxel in Advanced Squamous-Cell Non-Small-Cell Lung Cancer.

  2015cited by this paper
• Ultraviolet radiation-induced non-melanoma skin cancer: Regulation of DNA damage repair and inflammation

  2014cited by this paper
• Host characteristics, sun exposure, indoor tanning and risk of squamous cell carcinoma of the skin

  2014cited by this paper
• Safety and tumor responses with lambrolizumab (anti-PD-1) in melanoma.

  2013cited by this paper
• The blockade of immune checkpoints in cancer immunotherapy

  2012cited by this paper
• Safety and activity of anti-PD-L1 antibody in patients with advanced cancer.

  2012cited by this paper
• Tumor cell expression of programmed cell death‐1 ligand 1 is a prognostic factor for malignant melanoma

  2010cited by this paper
• Phase I study of single-agent anti-programmed death-1 (MDX-1106) in refractory solid tumors: safety, clinical activity, pharmacodynamics, and immunologic correlates.

  2010cited by this paper
• Analysis of risk factors determining prognosis of cutaneous squamous-cell carcinoma: a prospective study.

  2008cited by this paper
• PD-1 and PD-1 ligands: from discovery to clinical application.

  2007cited by this paper
• Suppression of expression and function of negative immune regulator PD-1 by certain pattern recognition and cytokine receptor signals associated with immune system danger.

  2004cited by this paper
• Involvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockade

  2002cited by this paper
• Induced expression of PD‐1, a novel member of the immunoglobulin gene superfamily, upon programmed cell death.

  1992cited by this paper
• Risk of subsequent basal cell carcinoma and squamous cell carcinoma of the skin among patients with prior skin cancer. Skin Cancer Prevention Study Group.

  1992cited by this paper

• CHANGES IN THE EXPRESSION OF REGULATORY RECEPTORS ON CD8 T CELLS AS RISK FACTORS FOR THE FORMATION OF LONG COVID IN PATIENTS AFTER A SEVERE COURSE OF COVID-19

  2025cites this paper